Keyphrases
Clozapine
100%
Schizophrenia
45%
Schizophrenic Patients
41%
Antidepressants
35%
Antipsychotics
34%
Organophosphate
30%
Clozapine Treatment
30%
Patients with Schizophrenia
30%
Brain Injury
21%
Vitamin D
21%
Psychosis
20%
Treatment-resistant Schizophrenia
18%
Bipolar Disorder
16%
Vitamin D Supplementation
14%
Bipolar Depression
14%
Rehospitalization
14%
All-cause Mortality
13%
Manic Episode
13%
Hospitalization
13%
Organophosphate Poisoning
13%
Psychiatrists
12%
Vitamin D Status
12%
Metabolic Syndrome
12%
Bipolar I Disorder
12%
Hazard Ratio
12%
Schizophrenia Symptoms
12%
Chemical Terrorism
12%
Hospitalization Rate
12%
Mortality Rate
11%
Mass Casualty Events
11%
Psychotic Disorders
11%
Increased Mortality
11%
Historical Prospective
10%
Low Adherence
10%
National Cohort Study
10%
Nerve Agents
10%
Mental Hospital
10%
Premature Mortality
10%
Pharmacokinetics
10%
Medical Management
10%
Inflammation
10%
Clozapine Rechallenge
10%
Depressive Episode
9%
Schizoaffective Disorder
9%
Community-based Study
9%
Jewish
9%
Nerve Agent Poisoning
9%
Postpartum Depression
9%
Psychiatry
9%
Population-based Cohort Study
9%
Pharmacology, Toxicology and Pharmaceutical Science
Clozapine
69%
Organophosphate
31%
Antidepressant
30%
Toxic Injury
29%
Disease
25%
Cohort Study
24%
Vitamin D
23%
Antipsychotic
20%
Symptom
18%
Nerve Gas
17%
Metabolic Syndrome X
15%
Psychosis
14%
Organophosphate Poisoning
13%
Mania
12%
Chemical Warfare Agent
12%
Biological Marker
11%
Placebo
10%
Adverse Event
10%
Oxime
10%
Mortality Rate
10%
Treatment-Resistant Schizophrenia
10%
All Cause Mortality
10%
Toxidrome
9%
Granulocyte Colony Stimulating Factor
9%
Glutamic Acid
9%
Paraoxon
9%
Neutropenia
9%
Comorbidity
9%
Typical Antipsychotic
8%
Bipolar I Disorder
8%
Ischemic Heart Disease
8%
Agranulocytosis
7%
Depression
6%
Midazolam
6%
Cardiovascular Disease
6%
Cytokine
6%
Inflammation
6%
Carbamic Acid
6%
Pharmacotherapy
6%
Antidepressant
5%
Prospective Study
5%
Vitamin D Deficiency
5%
Hypovitaminosis D
5%
Combination Therapy
5%
Tolerability
5%
Bipolar Disorder
5%
Premature Mortality
5%
Schizophrenia
5%
C Reactive Protein
5%
Side Effect
5%
